Altimmune, Inc. (ALT): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

88.10M
Year ended 2025-12-31
+23.4%
3-year compound annual growth
+28.0%
5-year compound annual growth
+3.3%
10-year compound annual growth
2014-12-31: 57.54M2015-12-31: 63.99M2016-12-31: 65.66M2020-12-31: 25.64M2021-12-31: 41.28M2022-12-31: 46.93M2023-12-31: 53.25M2024-12-31: 71.00M2025-12-31: 88.10M88.10M
2014-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3188.10M+24.1%2026-03-06, From 2025-01-01
2024-12-3171.00M+33.3%2026-03-06, From 2024-01-01
2023-12-3153.25M+13.5%2025-02-27, From 2023-01-01
2022-12-3146.93M+13.7%2024-03-27, From 2022-01-01
2021-12-3141.28M+61.0%2023-02-28, From 2021-01-01
2020-12-3125.64Mn/a2022-03-15, From 2020-01-01
No annual figure between 2016-12-31 and 2020-12-31.
2016-12-3165.66M+2.6%2017-03-14, From 2016-01-01
2015-12-3163.99M+11.2%2017-03-14, From 2015-01-01
2014-12-3157.54Mn/a2017-03-14, From 2014-01-01